help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ma, Y. H.
Right arrow Articles by Grodsky, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ma, Y. H.
Right arrow Articles by Grodsky, G. M.

Endocrinology, Vol 136, 2622-2630, Copyright © 1995 by Endocrine Society


ARTICLES

Constitutive (pro)insulin release from pancreas of transgenic mice expressing monomeric insulin

YH Ma, P Lores, J Wang, J Jami and GM Grodsky
Metabolic Research Unit, University of California, San Francisco 94143, USA.

To evaluate the role of protein aggregation and calcium in the sorting of insulin for regulated vs. constitutive release from the intact pancreas, we targeted the expression of a monomeric mutant form of human (pro)insulin (B9/B27) to the pancreatic beta-cells of transgenic mice. This mutant insulin does not form dimers or hexamers, but can aggregate at high concentration in the presence of calcium. A homozygous line (171) was produced that expressed 55% of the total (pro)insulin message in their beta-cells as the mutant form and had normal pancreatic total (pro)insulin content [measured as immunoreactive insulin (IRI)]. Fasting glucose levels in these transgenics and in homozygous control mice expressing native human (pro)insulin were normal, although levels were abnormally elevated during ip glucose tolerance testing. In the presence of extracellular calcium, regulated IRI release from the isolated perfused pancreas of the transgenic mice was undetectable in the absence of secretagogues and responded with normal phasic kinetics when stimulated with increasing steps of glucose, with glucose plus isobutylmethylxanthine, or with arginine. Without extracellular calcium (0 calcium plus EGTA), normal pancreas did not release IRI in either the presence or absence of secretagogues. In contrast, without calcium or secretagogues, transgenic pancreas spontaneously and constitutively released IRI at high levels equivalent to those elicited by glucose (22 mM) plus calcium from normal pancreas. This release was partially inhibited by glucose or arginine. Constitutive secretion was acutely sensitive to calcium; inhibition occurred within minutes after the addition of calcium and quickly returned to its characteristic level (with overshoot) when calcium was subsequently removed. Somatostatin, at a concentration that caused 50% inhibition of normal glucose-stimulated secretion, did not affect constitutive release. Control pancreas from the transgenic mice, expressing native human (pro)insulin, responded normally to secretagogues and did not constitutively release hormone in the absence of calcium. It is concluded that expression of monomeric human insulin in pancreatic beta-cells from transgenic mice did not interfere with normal phenotypic insulin secretion, indicating that the functional secretory apparatus was not impaired. Constitutive secretion of IRI from the intact pancreas requires both the expression of a monomeric form of insulin and the absence of extracellular calcium, two conditions that reduce aggregation. These results are consistent with the hypothesis that protein aggregation favors sorting to the regulated pathway, whereas suppressed aggregation causes sorting for constitutive release.


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
Y. Shi, J. Kanaani, V. Menard-Rose, Y. H. Ma, P.-Y. Chang, D. Hanahan, A. Tobin, G. Grodsky, and S. Baekkeskov
Increased expression of GAD65 and GABA in pancreatic beta -cells impairs first-phase insulin secretion
Am J Physiol Endocrinol Metab, September 1, 2000; 279(3): E684 - E694.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Nijenhuis, R. Zalm, and J. P. H. Burbach
Mutations in the Vasopressin Prohormone Involved in Diabetes Insipidus Impair Endoplasmic Reticulum Export but Not Sorting
J. Biol. Chem., July 23, 1999; 274(30): 21200 - 21208.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
P. S. Dannies
Protein Hormone Storage in Secretory Granules: Mechanisms for Concentration and Sorting
Endocr. Rev., February 1, 1999; 20(1): 3 - 21.
[Abstract] [Full Text]


Home page
BloodHome page
N. Borregaard and J. B. Cowland
Granules of the Human Neutrophilic Polymorphonuclear Leukocyte
Blood, May 15, 1997; 89(10): 3503 - 3521.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
U. Myrsen-Axcrona, S. Karlsson, F. Sundler, and B. Ahren
Dexamethasone Induces Neuropeptide Y (NPY) Expression and Impairs Insulin Release in the Insulin-producing Cell Line RINm5F. RELEASE OF NPY AND INSULIN THROUGH DIFFERENT PATHWAYS
J. Biol. Chem., April 18, 1997; 272(16): 10790 - 10796.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society